163 related articles for article (PubMed ID: 15720252)
1. Peripheral arterial disease: a missed opportunity to administer statins so as to reduce cardiac morbidity and mortality.
Daskalopoulou SS; Daskalopoulos ME; Liapis CD; Mikhailidis DP
Curr Med Chem; 2005; 12(4):443-52. PubMed ID: 15720252
[TBL] [Abstract][Full Text] [Related]
2. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
Coppola G; Novo S
Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
4. Statins and peripheral arterial disease: potential mechanisms and clinical benefits.
Alnaeb ME; Alobaid N; Seifalian AM; Mikhailidis DP; Hamilton G
Ann Vasc Surg; 2006 Sep; 20(5):696-705. PubMed ID: 16841271
[TBL] [Abstract][Full Text] [Related]
5. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
6. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease.
Feringa HH; Karagiannis SE; van Waning VH; Boersma E; Schouten O; Bax JJ; Poldermans D
J Vasc Surg; 2007 May; 45(5):936-43. PubMed ID: 17360142
[TBL] [Abstract][Full Text] [Related]
7. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
8. Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction.
Hirsch AT; Gotto AM
Vasc Med; 2002; 7(4):323-31. PubMed ID: 12710848
[TBL] [Abstract][Full Text] [Related]
9. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
10. Statins and peripheral arterial disease.
Markel A
Int Angiol; 2015 Oct; 34(5):416-27. PubMed ID: 25410295
[TBL] [Abstract][Full Text] [Related]
11. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
[TBL] [Abstract][Full Text] [Related]
12. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
13. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
McKenney JM
Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846
[TBL] [Abstract][Full Text] [Related]
15. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].
Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR
Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165
[TBL] [Abstract][Full Text] [Related]
16. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.
Law MR; Wald NJ; Rudnicka AR
BMJ; 2003 Jun; 326(7404):1423. PubMed ID: 12829554
[TBL] [Abstract][Full Text] [Related]
17. Managing dyslipidemia in the high-risk patient.
Stein EA
Am J Cardiol; 2002 Mar; 89(5A):50C-57C. PubMed ID: 11900720
[TBL] [Abstract][Full Text] [Related]
18. Statins and infrainguinal vascular bypass procedures.
Paraskevas KI; Giannoukas AD; Mikhailidis DP
Curr Vasc Pharmacol; 2013 Jan; 11(1):51-7. PubMed ID: 23391423
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
20. The benefit of statins in non-cardiac vascular surgery patients.
Stalenhoef AF
J Vasc Surg; 2009 Jan; 49(1):260-5. PubMed ID: 19174265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]